Biochemical and Toxicological Evaluation of Atorvastatin and Riboflavin in Diethylnitrosamine Induced Hepatocellular Carcinoma
Kaleemuddin Mohammed, Saida Sadath, Tariq Jamal, Syed Shoeb Razvi, Abdulaziz Al-Orabi, Ali H. Aseeri, Fahad A. Al-Abbasi & Firoz Anwar · Journal of Pharmaceutical Research International · 2018
Background: Atorvastatin, a commonly prescribed drug for the management of hyperlipidemia, acts as competitive inhibitors of HMG-CoA reductase—a rate-limiting enzyme in cholesterol synthesis. On the other hand, riboflavin is also a well-studied micronutrient known for its anti-pr...
Open access
Research Article
10.9734/JPRI/2018/39652